Invention Grant
- Patent Title: Three-dimensional culture of primary cancer cells using tumor tissue
-
Application No.: US16494273Application Date: 2018-03-15
-
Publication No.: US11549100B2Publication Date: 2023-01-10
- Inventor: Hideaki Kakinuma , Yukiko Shimada , Hiroaki Inoue , Takashi Morikawa
- Applicant: LSI MEDIENCE CORPORATION
- Applicant Address: JP Tokyo
- Assignee: LSI MEDIENCE CORPORATION
- Current Assignee: LSI MEDIENCE CORPORATION
- Current Assignee Address: JP Tokyo
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: JPJP2017-051612 20170316
- International Application: PCT/JP2018/010247 WO 20180315
- International Announcement: WO2018/169007 WO 20180920
- Main IPC: C12N5/09
- IPC: C12N5/09 ; G01N33/50

Abstract:
A method of producing a cell mass by three-dimensional culture of primary cancer cells having proliferative ability and properties of handleability, versatility, and high-throughput performance, in which a tumor tissue is used as a starting material, proliferation of cells such as fibroblasts other than cancer cells is inhibited, and the cell mass includes primary cancer cells as a main component. The object is achieved by providing a method of producing a cell mass by three-dimensional culture of primary cancer cells using a tumor tissue, including: a three-dimensional culture step of culturing cells obtained from the tumor tissue in a medium containing a 5% v/v or less extracellular matrix on a substantially low-adhesive cell culture substrate.
Public/Granted literature
- US20200071676A1 THREE-DIMENSIONAL CULTURE OF PRIMARY CANCER CELLS USING TUMOR TISSUE Public/Granted day:2020-03-05
Information query